Skip to main content
Download PDF

Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019

BMC Public Health volume 23, Article number: 2120 (2023) Cite this article

Abstract

Background

Stroke is a major cause of acute neurological symptoms in children with significant long-term neurological sequelae. However, data of diseases burden on stroke among children was lack. We aimed to be dedicated to analyze and compare global trends as well as regional and sociodemographic differences in stroke prevalence, incidence, mortality and disability-adjusted life-years (DALYs) among children aged 0 ~ 14 years.

Method

We obtained data on annual number of incident strokes, prevalent strokes, deaths, and DALYs, age-standardized incidence rates (ASIRs), prevalence rates (ASPRs), mortality rates (ASMRs) and DALY rates (ASDRs) of stroke among individuals aged 14 years and younger during 1990–2019 from the 2019 Global Burden of Disease Study. To quantify the temporal trends, we calculated changes (%) in number, and used joinpoint regression analysis to identify the average annual percentage changes (AAPCs) of age standardized rates.

Result

Globally, the incident strokes and prevalent strokes increased by 18.51% and 31.97%, respectively, but DALYs due to stroke and deaths due to stroke decreased by 60.18% and 65.03%, respectively, from 1990 to 2019. During the same period, ASIR increased by 0.21% (95%CI: 0.17, 0.24) from 18.02 to 100,000 population in 1990 to 19.11 per 100,000 in 2019; ASPR increased by 0.66% (95%CI: 0.36, 0.96) from 68.88 to 100,000 population in 1990 to 81.35 per 100,000 in 2019; while ASMR (AAPC= -3.94; 95%CI: -4.07, -3.81) and ASDR (AAPC= -3.50; 95%CI: -3.64, -3.36) both decreased. In 2019, the highest age standardized incidence, prevalence, mortality, and DALY rates all occurred in low sociodemographic index (SDI) regions. The greatest increase of age standardized incidence rate (AAPC = 0.21; 95%CI: 0.18, 0.25) and prevalence rate (AAPC = 1.15; 95%CI: 0.34, 1.96) both were in high SDI regions. Eastern Sub-Saharan Africa had the highest ASIR and ASPR in 2019, and Oceania had the highest ASMR and ASDR in 2019 across 21 GBD regions. High-income North America had the largest increase in ASIR (AAPC = 0.63; 95%CI: 0.59, 0.66) and ASPR (AAPC = 1.58; 95%CI: 0.54, 2.63). Against the overall decreasing trend of ASMR, an increasing trend of ASMR was found in Zimbabwe (AAPC = 0.91; 95%CI: 0.44, 1.37) and Botswana (AAPC = 0.74; 95%CI: 0.02, 1.47).

Conclusion

The overall increasing stroke incidence and prevalence indicated that prevention and management of stroke among younger population should be critical in the future. Despite stroke mortality with falling trend worldwide, specific countries or territories present worrying increase in stroke mortality. Without urgent implementation of effective primary prevention strategies, the stroke burden of children will probably continue to grow across the world, particularly in high-SDI countries.

Peer Review reports

Introduction

A large number of deaths and disabilities were from stroke, remaining the second-leading cause of death and the third-leading cause of disability in 2019 worldwide [1]. There were more than 100 million prevalent stroke cases and disability-adjusted life-years (DALYs) due to stroke, and 12.2 million incident stroke cases with 6.55 million deaths due to stroke in 2019 [1]. Stroke is primarily considered as a neurological disorder of the elderly, while in recent years, the increasing number of studies reported that stroke occurred in younger people, even children.

Childhood strokes further are subdivided into three groups: perinatal stroke, stroke in infancy and early childhood and adolescent stroke [2, 3]. Previous studies reported that the prevalence of strokes ranged from 2.9 to 28% in children [4, 5]. A nationwide Swedish registers identified 1606 individuals aged less than 18 years old with ischemic stroke between 1969 and 2016 [6]. Sharma et al. reported that 48 children had haemorrhagic stroke [7]. Stroke results from a multifactorial background in both children and in adults. However, it differs in children, compared that in adults. Previous studies showed that central nervous system infections, vitamin K deficiency-related bleeding disorder, inherited coagulation disorders, and arteriovenous malformations were the most common risk factors for childhood stroke [4, 7,8,9]. Compare with genetic risk factors, non-genetic risk factors, such as environmental factors (which are common in adults) seem to have low or no clinical relevance in children [10, 11].

Disease patterns, population distribution, and sociodemographic factors continue to change the stroke epidemic across the world. Previous publications on the stroke burden in the core Global Burden of Disease (GBD) study did not report analyses among children. In the present study, we retrieved detailed data on the prevalence, incidence, mortality and DALYs of stroke among children aged 14 years and younger from the 2019 GBD study, which provided a global landscape of the epidemic trend of stroke.

Method

Data source

We conducted a post hoc analysis of the GBD 2019. The Institute for Health Metrics and Evaluation at the University of Washington, USA, coordinated the GBD study as a systematic and scientific effort on quantifying the comparative magnitude of health losses due to diseases at sex, age, region and country level over time [12]. In short, stroke was defined as rapidly developing clinical signs of disturbance of cerebral function (usually focal) lasting more than 24 h or leading to death based on WHO clinical criteria [13]. As GBD 2019 only provided data of children aged 14 years and younger age among children younger than 18 years old, we obtained 19-year (1990–2019) annual absolute number, age-standardized incidence rates (ASIRs), prevalence rates (ASPRs), mortality rates (ASMRs) and DALY rates (ASDRs) of stroke in children aged 14 years and younger by sex, region, and country from the website Global Health Data Exchange [12]. The detail methods are shown in elsewhere [1]. In short, deaths were estimated using vital registration and verbal autopsy data in the cause of death ensemble modelling (CODEm) framework. Incidence, prevalence, and mortality were generated by using the Bayesian meta-regression (DisMod-MR 2.1) modelling tool based on all available high-quality related data [1]. As this study used model data, ethical review and informed consent were not required.

Sociodemographic index, regions and demographics

The sociodemographic index (SDI) as a composite indicator, was the weighted geometric mean of three rescaled components including income per capita, average educational attainment in population aged 15 years or older and total fertility rates under age 25 years [14]. It ranged from zero to one, with a higher value reflected a theoretical higher level of development status relevant to health outcomes. All 204 countries or territories were classified into five SDI regions, including low, low-middle, middle, high-middle and high SDI regions.

According to epidemiological homogeneity and geographical contiguity, all 204 countries or territories were separated into 21 GBD regions, including High-income Asia Pacific, Central Asia and others [15].

Statistical analysis

The absolute number with 95% uncertainty intervals (UIs) of prevalent strokes, incident strokes, deaths due to stroke and DALYs due to stroke, and age-standardized rate with 95% UIs were used to indicate epidemic status [16]. The relative changes of absolute number from 1990 to 2019 were calculated, defining as

$$\frac{{\text{n}\text{u}\text{m}\text{b}\text{e}\text{r}}_{2019}-{\text{n}\text{u}\text{m}\text{b}\text{e}\text{r}}_{1990}}{{\text{n}\text{u}\text{m}\text{b}\text{e}\text{r}}_{1990}}\times 100\text{\%}$$

Average annual percentage change (AAPC) as a summary and widely used measure of the trend of age-standardized rate, was calculated by using Joinpoint regression analysis [17,18,19]. Joinpoint regression analysis assessed the trend of the ASR over a specified time interval on a logarithmic scale. In this study, number of joinpoints ranged from zero to five was added. Joinpoint regression analysis tested every group for significance using a Monte Carlo permutation method, selected the best suitable model, and estimated AAPC with 95% confidential interval (CI) which provides a single summary number for the trend over the past 30 years [18, 20]. Joinpoint regression analyses were performed by joinpoint regression program (Version 4.9.1.0 - Nov 2022; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute).

To investigate the potential influence factors of the AAPC at the national level, we applied Pearson correlation analysis to assess the correlation of AAPCs with age-standardized incidence (ASIR), prevalence (ASPR), mortality (ASMR), and DALY rates (ASDR) as well as with SDI values (2019) in 204 countries and territories. Polynomial curves were used to present results of analysis. Except Joinpoint regression analyses, other analysis was conducted by R (version 4.1.0). A two-tailed P value less than 0.05 was statistically significant. This manuscript conforms to the STROBE guidelines for observational cohort studies [21].

Result

Global trends in stroke prevalence, incidence, mortality and DALY rate

In 2019, there were 374,509.14 (95% UI: 256,946.45, 531,678.85) incident strokes (Table 1) and 1,594,311.22 (95% UI: 1,205,044.34, 2,110,296.06) prevalent strokes (Table S1), 1,678,539.47 (95% UI: 1,390,409.59, 2,034,897.27) DALYs due to stroke (Table S2), and 16,104.92 (95% UI: 13,102.73, 20,177.15) deaths due to stroke (Table 2). The absolute number of incident strokes globally increased by 18.51% from 1990 to 2019, prevalent strokes increased by 31.97%, but DALYs due to stroke decreased by 60.18%, deaths due to stroke decreased by 65.03%. Similarly, age-standardized rates both increased by 0.21% (95% CI: 0.17, 0.24) for incidence from 18.02 to 100,000 population in 1990 to 19.11 per 100,000 in 2019; by 0.66% (95% CI: 0.36, 0.96) for prevalence from 68.88 to 100,000 population in 1990 to 81.35 per 100,000 in 2019. The age-standardized mortality rate (AAPC= -3.94; 95% CI: -4.07, -3.81) and age-standardized DALY rate (AAPC= -3.50; 95% CI: -3.64, -3.36) both decreased.

Table 1 The incident strokes and age-standardized incidence rate and their temporal change among children (0–14 years), 1990 − 2019
Full size table
Table 2 The deaths and age-standardized morality rate and their temporal change among children (0–14 years), 1990 − 2019
Full size table

Regional trend in stroke prevalence, incidence, mortality and DALY rate in five SDI regions

The number of incident strokes, prevalent strokes, stroke-related deaths and stroke-related DALYs in 2019 and their changes during the past three decades all were highest in low SDI region (Table S1-S2, Tables 1 and 2). In 2019, the highest age-standardized incidence, prevalence, mortality, and DALY rates occurred in low SDI regions (Table S1-S2, Tables 1 and 2). The greatest increase of age-standardized incidence (AAPC = 0.21; 95% CI: 0.18, 0.25) and prevalence (AAPC = 1.15; 95% CI: 0.34, 1.96) both were in high SDI regions (Table S1, Table 1). The age-standardized mortality rate and DALY rate decreased across five SDI regions; the greatest decline was in high-middle SDI regions (AAPC= -6.24; 95% CI: -6.50, -5.98) for mortality and in middle SDI regions (AAPC= -4.89; 95% CI: -5.25, -4.54) for DALY rate (Table S2, Table 2).

Regional trend in stroke prevalence, incidence, mortality and DALY rate in 21 GBD regions

For GBD regions, there were nine regions with more than ten thousand incident strokes and six regions with more than one hundred thousand prevalent strokes in 2019, which of them, South Asia suffered the severest threat with 97,871.28 incident cases (95% UI: 66,360.11, 139,791.43) and 380,293.98 prevalent strokes (95% UI: 273,753.18, 530,164.66). Western Sub-Saharan Africa had the largest increase number of incident cases and prevalent strokes. Sub-Saharan Africa (Eastern Sub-Saharan Africa, Southern Sub-Saharan Africa and Western Sub-Saharan Africa, Central Sub-Saharan Africa), Caribbean and Tropical Latin America suffered the severe threat with high age-standardized incidence rate, which of them, Eastern Sub-Saharan Africa had an increase by 0.04% (95% CI: 0.02, 0.07) from 28.68 to 100,000 population in 1990 to 28.89 per 100,000 in 2019 (Table 1). Sub-Saharan Africa (Eastern Sub-Saharan Africa, Southern Sub-Saharan Africa and Western Sub-Saharan Africa) also suffered the severe threat with high age-standardized prevalence rate, which of them, Eastern Sub-Saharan Africa had an increase by 0.37% (95% CI: 0.19, 0.56) from 134.84 to 100,000 population in 1990 to 148.43 per 100,000 in 2019 (Table S1). Meanwhile, High-income North America had the largest increase in ASIR (AAPC = 0.63; 95% CI: 0.59, 0.66) and ASPR (AAPC = 1.58; 95% CI: 0.54, 2.63) across 21 GBD regions (Table S1 and Table 1).

Although absolute numbers of deaths and DALYs decreased over the study period in other 19 GBD regions, it increased in Oceania and Western Sub-Saharan Africa. Oceania had the largest increase in absolute numbers of deaths (73.24%) and DALYs (73.44%), besides, it had the largest age-standardized mortality (3.32 per 100,000 population) and DALY rate (301.66 per 100,000 population) in 2019 across 21 GBD regions. Western Sub-Saharan Africa had the largest absolute numbers of deaths (4,535.32) and DALYs (420,873.60) in 2019. The largest decline in age-standardized mortality (AAPC= -7.96; 95% CI: -8.46, -7.45) and DALY rate (AAPC= -6.64; 95% CI: -7.04, -6.24) occurred in East Asia (Table S2 and Table 2).

National trend in stroke prevalence, incidence, mortality and DALY rate

At the country level in 2019, the ASIR for stroke was highest in Mozambique (35.71 per 100,000 population), followed by Burundi (32.23 per 100,000 population) and Somalia (31.26 per 100,000 population) (Fig. 1 and Table S3). The ASPR of stroke varied significantly across the 204 countries and territories. In 2019, the largest ASPR was in Mozambique (ASPR, 183.37 per 100,000 population), followed by Kenya (ASPR, 172.61 per 100,000) and Malawi (ASPR, 171.45 per 100,000) (Table S4). In 2019, across all the countries or territories, ASMR was highest in the Egypt (ASMR, 6.23 per 100,000 population), followed by Sierra Leone and Haiti (Fig. 2 and Table S5). Over the study period, Zimbabwe (AAPC = 0.91; 95% CI: 0.44, 1.37) and Botswana (AAPC = 0.74; 95% CI: 0.02, 1.47) were the only two countries with increasing trend of ASMR across 204 countries or territories (Fig. 2 and Table S5). Similarly, Egypt had the highest number of DALYs and ASDR across all the countries or territories in 2019 (Table S6). The detailed results of national trends in stroke incidence, prevalence, mortality and DALY rate are shown in the Table S3-S6.

Fig. 1
figure 1

Global trends in stroke incidence among children (0–14 years) in 204 countries and territories. (A) age-standardized incidence rates in 2019; (B) changes in incident strokes between 1990 and 2019; (C) AAPCs of age-standardized incidence rates from 1990 to 2019. ASIR, age-standardized incidence rate; AAPC, average annual percentage change

Full size image
Fig. 2
figure 2

Global trends in stroke mortality among children (0–14 years) in 204 countries and territories. (A) age-standardized mortality rates in 2019; (B) changes in deaths from strokes between 1990 and 2019; (C) AAPCs of age-standardized mortality rates from 1990 to 2019. ASMR, age-standardized mortality rate; AAPC, average annual percentage change

Full size image

Influence factors associated with AAPC

A positive correlation was observed between AAPC of ASIR and ASIR in 2019 (ρ = 0.35, P < 0.001). In 2019, a significant negative correlation was detected between AAPC of ASIR and SDI (ρ= -0.21, P = 0.003) (Fig. 3A). Moreover, a significant positive correlation was observed between AAPC of ASMR and ASMR (ρ = 0.40, P < 0.001), and a significant negative correlation was found between AAPC of ASMR and SDI (ρ= -0.45, P < 0.001) (Fig. 3B). There was no correlation between AAPC of ASPR/ASDR and ASPR/ASDR or SDI (Figure S1).

Fig. 3
figure 3

Average annual percentage changes of age-standardized incidence rates and age-standardized mortality rates of stroke at the country and territorial levels. (A) Correlation of average annual percentage changes with age-standardized incidence rates and sociodemographic indexes in 2019. (B) Correlation of average annual percentage changes with age-standardized mortality rates and sociodemographic indexes in 2019. The incident strokes and deaths from stroke from 204 countries and territories are represented by the circles. The circle size reflects the number of incident strokes and deaths from stroke. AAPC, average annual percentage change; ASIR, age-standardized incidence rate; ASMR, age-standardized mortality rate; SDI, sociodemographic index

Full size image

Discussion

This study used data from 2019 GBD study and systematically evaluated global trends and regional differences in stroke prevalence, incidence, mortality and DALY rate as well as the association with SDI at the national level among children aged less than 14 years. Findings of this study provided the comprehensive distribution and trend of stroke burden in children. We found that global incident strokes, ASIR, prevalent strokes and ASPR all increased, while deaths, ASMR, DALYs and ASDR all decreased over the past thirty years. In 2019, the highest age standardized incidence, prevalence, mortality, and DALY rates all occurred in low SDI regions. The greatest increase of age standardized incidence and prevalence both were in high SDI regions. Eastern Sub-Saharan Africa had the highest ASIR and ASPR in 2019, and Oceania had the highest ASMR and ASDR in 2019 across 21 GBD regions. High-income North America had the largest increase in ASIR and ASPR across 21 GBD regions. Against the overall decreasing trend of ASMR and ASDR, an increasing trend of them was found in Zimbabwe and Botswana. At the national level, we found a positive association of AAPC for ASIR or ASMR with ASIR or ASMR and a negative association of AAPC for ASIR or ASMR with SDI.

Our study provided more detail results and converse findings for children. GBD 2019 study reported that in general population, from 1990 to 2019, the global number of incident strokes and prevalent strokes both increased by over 70%, which was similar with our findings [1]. Our study also found that global incident strokes increased by 18.51%, and prevalent strokes increased by 31.97% among children. However, in contrast to the decreasing trend of stroke incidence and prevalence among general population, during the same period, we found that ASIR and ASPR both increased by 0.21% and 0.66% per year, respectively [1]. To be specific, high SDI regions had the greatest increase of ASIR and ASPR, and High-income North America had the largest increase across 21 GBD regions. Sundelin et al. also reported that the increasing number of childhood ischemic stroke from 1969 to 2016, and the highest number of childhood ischemic stroke reaching 1019 from 1997 to 2016 in Sweden [6]. Developed countries seem to present a greater burden of childhood stroke in the past decade [22]. Our findings revealed that the future clinical management and public health policy formulation should focus on this disease burden in childhood, not just for adults and older people. In fact, risk factors of stroke mainly were in adulthood such as atherosclerosis have been confirmed they began to present in childhood [23]. Multifactorial background of stroke occurrence in children is different from adults. Genetic risk factors have more clinical relevance, compared with non-genetic risk factors—environmental factors in children [10, 11]. In order to address this important global public health concern, continued efforts on screening the trend of stroke diseases burden and its modifiable risk factors, studying cutting-edge clinical assessment methods and techniques with higher sensitivity and specificity, and developing education programs of diagnosis and management in multidisciplinary medical personnel including cardiologists, hematologists, and cardiac intensivists, etc., were critical. Our study provided the updated and basic information of epidemiological distribution and pattern in this field.

In the general population, deaths due to stroke and DALYs due to stroke both increased, while mortality and DALY rate both decreased [1]. Similar results about trend of morality and DALY rate were found in children. In addition, we also found that the global number of DALYs and deaths decreased from 1990 to 2019. Although age-specific technical guidelines or recommendations for childhood stroke patients are unclear, the related technical development and drug therapy have reduced the risk of death from stroke [24,25,26,27,28]. For example, endovascular therapy was proposed to use for acute stroke among at least some children by experienced operators in an increasing number of reports [29]. This decline in childhood stroke morality and DALY may reflect improving recognition and poststroke medical management at global level. However, children in some regions or countries still faced a higher risk of death due to stroke. An increasing trend of ASMR and ASDR was found in Zimbabwe and Botswana. Additionally, in 2019, the number of stroke-related deaths and DALYs, ASMR and ASDR all were highest in low SDI region. Liesl Zühlke et al. found that patients from low- and lower-middle–income countries had significantly higher age- and sex-adjusted mortality than patients from upper-middle–income countries [30]. A large, multinational, prospective cohort reported that low income was associated with worse neurologic outcomes compared to higher income levels among children with arterial ischemic stroke [31]. Diagnosis, therapeutic interventions and management of stroke was relatively behindhand in low-income countries, international collaboration is desired to help in capacity building and research [32]. Higher mortality and DALY rate may reflect a poorer access to healthcare, limited availability of advanced treatment, and lower rates of hospitalization for stroke in developing regions [33]. Despite the decreased mortality and DALY rate, the regional gap should be paid attention.

There still had several limitations in this study. Firstly, the most notable limitation of this analysis was that the accuracy and robustness of GBD estimates largely depend on the quality and quantity of data used in the modelling [16]. For countries where national systematic surveillance and population-based studies were lacking or insufficient, the estimates might be a margin of bias. Secondly, due to GBD only provided data of population aged 14 years and over, not more specific age group, we could not analysis this population in detail.

Conclusion

In conclusion, the overall increasing stroke incidence and prevalence indicated that prevention and management of stroke among younger population should be critical in the future. Despite falling trend in stroke mortality worldwide, specific countries or territories present worrying increase in stroke mortality. Without urgent implementation of effective primary prevention strategies, the stroke burden of children will probably continue to grow across the world, particularly in high-SDI countries.

Data Availability

The datasets generated during and/or analyzed during the current study are available in the GBD repository, [http://ghdx.healthdata.org/gbd-results-tool].

References

  1. Global regional. National burden of Stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.

    Article  Google Scholar 

  2. Vinayan KP, Nambiar V, Anand V. Acute ischemic Stroke in children - should we thrombolyze? Ann Indian Acad Neurol. 2022;25(1):21–5.

    Article  CAS  PubMed  Google Scholar 

  3. Tierradentro-García LO, Zandifar A, Ullman NL, Venkatakrishna SSB, Kim JDU, Martin RJ, et al. Imaging of suspected Stroke in children, from the AJR Special Series on Emergency Radiology. AJR Am J Roentgenol. 2023;220(3):330–42.

    Article  PubMed  Google Scholar 

  4. Zadeh C, AlArab N, Muwakkit S, Atweh LA, Tamim H, Makki M, et al. Stroke in Middle Eastern children with cancer: prevalence and risk factors. BMC Neurol. 2022;22(1):31.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Thangappan K, Haney LC, Riggs K, Chen S, Mehegan M, VanderPluym C, et al. Children who stroke on VAD support: when is it safe to transplant and what are their outcomes? Artif Organs. 2022;46(7):1389–98.

    Article  PubMed  Google Scholar 

  6. Sundelin HEK, Walås A, Söderling J, Bang P, Ludvigsson JF. Long-term mortality in children with ischemic Stroke: a Nationwide Register-based Cohort Study. Stroke. 2022;53(3):837–44.

    Article  PubMed  Google Scholar 

  7. Sharma S, Suthar R, Dhawan SR, Ahuja CK, Bhatia P, Baranwal AK, et al. Aetiological Profile and short-term neurological outcome of Haemorrhagic Stroke in Children. J Trop Pediatr. 2022;68(4):fmac040.

    Article  PubMed  Google Scholar 

  8. Grose C, Shaban A, Fullerton HJ. Common features between Stroke following varicella in children and Stroke following herpes zoster in adults: Varicella-Zoster Virus in Trigeminal Ganglion. Curr Top Microbiol Immunol. 2023;438:247–72.

    CAS  PubMed  Google Scholar 

  9. Solomons RS, Nieuwoudt ST, Seddon JA, van Toorn R. Risk factors for ischemic Stroke in children with tuberculous Meningitis. Childs Nerv Syst. 2021;37(8):2625–34.

    Article  PubMed  Google Scholar 

  10. Sarecka-Hujar B, Kopyta I. Introduction to the special issue on ischemic Stroke in children. Child (Basel). 2022;9(6):832.

    Google Scholar 

  11. Wilson JL, Dowling M, Fullerton HJ. Stroke in children. Stroke. 2021;52(10):3388–90.

    Article  PubMed  Google Scholar 

  12. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017. (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2018. Available from http://ghdx.healthdata.org/gbd-results-tool. Cited 2023 Sep 24.

  13. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular Disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019. (GBD 2019) Socio-Demographic Index (SDI) 1950–2019. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020. Available from https://ghdx.healthdata.org/record/ihme-data/gbd-2019-socio-demographic-index-sdi-1950-2019. Cited 2023 Sep 24.

  15. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.

    Article  PubMed  Google Scholar 

  16. Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, et al. The trends in incidence of primary Liver cancer caused by specific etiologies: results from the global burden of Disease Study 2016 and implications for Liver cancer prevention. J Hepatol. 2019;70(4):674–83.

    Article  PubMed  Google Scholar 

  17. Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and national burdens of HIV and other sexually transmitted Infections in adolescents and young adults aged 10–24 years from 1990 to 2019: a trend analysis based on the global burden of Disease Study 2019. Lancet Child Adolesc Health. 2022;6(11):763–76.

    Article  PubMed  Google Scholar 

  18. Schuster-Bruce J, Jani C, Goodall R, Kim D, Hughes W, Salciccioli JD, et al. A comparison of the burden of thyroid Cancer among the European Union 15 + countries, 1990–2019: estimates from the global burden of Disease Study. JAMA Otolaryngol Head Neck Surg. 2022;148(4):350–59.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Wu D, Wong P, Guo C, Tam LS, Gu J. Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the global burden of Disease Study 2017. BMC Med. 2021;19(1):34.

    Article  PubMed  PubMed Central  Google Scholar 

  20. joinpoint. Available from https://surveillance.cancer.gov/help/joinpoint/. Cited 2023 Sep 24.

  21. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.

    Article  Google Scholar 

  22. Ferriero DM, Fullerton HJ, Bernard TJ, Billinghurst L, Daniels SR, DeBaun MR, et al. Management of Stroke in neonates and children: A Scientific Statement from the American Heart Association/American Stroke Association. Stroke. 2019;50(3):e51–e96.

    Article  PubMed  Google Scholar 

  23. Poisson SN, Hills NK, Sidney S, Fullerton HJ. Prevalence of atherosclerotic risk factors among children and young adults with arterial ischemic Stroke. JAMA Neurol. 2022;79(9):901–10.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lo WD, Hajek C, Pappa C, Wang W, Zumberge N. Outcomes in children with hemorrhagic Stroke. JAMA Neurol. 2013;70(1):66–71.

    Article  PubMed  Google Scholar 

  25. Lehman LL, Fullerton HJ. Changing ethnic disparity in ischemic Stroke mortality in US children after the STOP trial. JAMA Pediatr. 2013;167(8):754–8.

    Article  PubMed  Google Scholar 

  26. Abdullahi SU, Jibir BW, Bello-Manga H, Gambo S, Inuwa H, Tijjani AG, et al. Hydroxyurea for primary Stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. Lancet Haematol. 2022;9(1):e26–e37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Amlie-Lefond C, Shaw DWW, Cooper A, Wainwright MS, Kirton A, Felling RJ, et al. Risk of intracranial Hemorrhage following intravenous tPA (tissue-Type plasminogen activator) for Acute Stroke is low in children. Stroke. 2020;51(2):542–48.

    Article  PubMed  Google Scholar 

  28. Amlie-Lefond C, Wainwright MS. Organizing for Acute arterial ischemic Stroke in children. Stroke. 2019;50(12):3662–68.

    Article  PubMed  Google Scholar 

  29. Sun LR, Harrar D, Drocton G, Castillo-Pinto C, Gailloud P, Pearl MS. Endovascular therapy for acute Stroke in children: age and size technical limitations. J Neurointerv Surg. 2021;13(9):794–98.

    Article  PubMed  Google Scholar 

  30. Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical outcomes in 3343 children and adults with Rheumatic Heart Disease from 14 low- and Middle-Income countries: two-year Follow-Up of the global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 2016;134(19):1456–66.

    Article  PubMed  Google Scholar 

  31. Jordan LC, Hills NK, Fox CK, Ichord RN, Pergami P, deVeber GA, et al. Socioeconomic determinants of outcome after childhood arterial ischemic Stroke. Neurology. 2018;91(6):e509–e16.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bhattacharya P, Sarmah D, Dave KR, Goswami A, Watanabe M, Wang X, et al. Stroke and Stroke prevention in sickle cell anemia in developed and selected developing countries. J Neurol Sci. 2021;427:117510.

    Article  PubMed  Google Scholar 

  33. Krishnamurthi RV, deVeber G, Feigin VL, Barker-Collo S, Fullerton H, Mackay MT, et al. Stroke prevalence, mortality and disability-adjusted life years in children and Youth aged 0–19 years: data from the Global and Regional Burden of Stroke 2013. Neuroepidemiology. 2015;45(3):177–89.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate the works by the Global Burden of Disease study 2019 collaborators.

Funding

This work was partly supported by the National Natural Science Foundation of China (72122001).

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No.38, Xueyuan Road, Haidian District, Beijing, 100191, China

    Min Du, Min Liu & Jue Liu

  2. Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, 119 South Fourth Ring West Road, Fengtai District, Beijing, 100871, China

    Donghua Mi

  3. Institute for Global Health and Development, Peking University, No.5, Yiheyuan Road, Haidian District, Beijing, 100871, China

    Jue Liu

Authors
  1. Min Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donghua Mi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jue Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MD, ML and JL conceptualised and designed the study, MD did data acquisition, data curation and formal analysis. MD did visualization, MD did writing - original draft, JL, DM and ML did writing- reviewing and editing. All authors have seen and approved the submitted version of this manuscript.

Corresponding author

Correspondence to Jue Liu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Conflict of interest

Authors declare no conflict of interest with the content of this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Du, M., Mi, D., Liu, M. et al. Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019. BMC Public Health 23, 2120 (2023). https://doi.org/10.1186/s12889-023-17046-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-023-17046-z

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us